Anlon Healthcare Limited (NSE:AHCL)

Market Cap	7.70B
Revenue (ttm)	1.70B +155.3%
Net Income	346.64M +258.9%
EPS	7.84 +17.4%
Shares Out	53.15M
PE Ratio	18.46
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	305,947
Average Volume	353,860
Open	143.35
Previous Close	141.23
Day's Range	140.35 - 143.35
52-Week Range	90.78 - 172.75
Beta	n/a
RSI	74.92
Earnings Date	Aug 21, 2026

About Anlon Healthcare

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumat...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2013
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AHCL

Financial Performance

In fiscal year 2025, Anlon Healthcare's revenue was 1.20 billion, an increase of 80.64% compared to the previous year's 666.16 million. Earnings were 205.18 million, an increase of 112.46%.